Parithera: Funding, Investors & Team (Oct 2026)
Precision oncology includes new ways of treating cancer such as targeted therapies and immunotherapies. These approaches are more specific and effective than current treatments. In the near future, they will considerably reduce worldwide cancer burden. As of today, only a fraction of the 18 million yearly diagnosed patients benefit from precision oncology. To increase the number of beneficiaries, new diagnostic tools are needed to match the specific needs of precision oncology to define patients' eligibility and monitor treatment response.
Parithera has raised $100k across 1 funding round on record, the most recent a Grant of $100k announced in Nov 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Parithera Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Parithera Funding Rounds
Parithera Founders and Leadership Team
No contact details are on record for this team yet.
Parithera Funding Compared to Other Health Care Startups
Parithera's latest round of $100k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Parithera in Health Care and Little Switzerland
Companies Similar to Parithera
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Parithera Funding FAQs
What does Parithera do?
Precision oncology includes new ways of treating cancer such as targeted therapies and immunotherapies. These approaches are more specific and effective than current treatments. In the near future, they will considerably reduce worldwide cancer burden. As of today, only a fraction of the 18 million yearly diagnosed patients benefit from precision oncology. To increase the number of beneficiaries, new diagnostic tools are needed to match the specific needs of precision oncology to define patients' eligibility and monitor treatment response.
How much funding has Parithera raised?
Parithera has raised $100k across 1 round on record. The most recent is a Grant of $100k announced in Nov 2021.
When did Parithera last raise funding?
Parithera's most recent funding round on record is a Grant of $100k, announced in Nov 2021.
Who is the CEO of Parithera?
Antoine Herzog is listed as CEO at Parithera.
Where is Parithera headquartered?
Parithera is based in Little Switzerland, North Carolina, United States.
How many employees does Parithera have?
Parithera is in the 1-10 employee band.
How does Parithera's funding compare to other Health Care startups?
Parithera's latest round of $100k is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Parithera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Parithera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.